Voriconazole topical cream formulation: evidence for stability and antifungal activity.


Journal

International journal of antimicrobial agents
ISSN: 1872-7913
Titre abrégé: Int J Antimicrob Agents
Pays: Netherlands
ID NLM: 9111860

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 09 04 2020
revised: 22 06 2020
accepted: 05 07 2020
pubmed: 14 7 2020
medline: 20 5 2021
entrez: 14 7 2020
Statut: ppublish

Résumé

Systemic use of voriconazole (VCZ) might be restricted by adverse events, such as hepatotoxicity and neurotoxicity, or drug-drug interactions. Topical VCZ application to skin may help to treat local infection more effectively and limit unwanted whole-body exposure. Topical VCZ cream was stable for 90 days when refrigerated. A patient with cutaneous Fusarium solani infection on his right forearm was successfully treated with topical 1% VCZ cream after failure of oral VCZ treatment.

Identifiants

pubmed: 32659465
pii: S0924-8579(20)30253-3
doi: 10.1016/j.ijantimicag.2020.106083
pii:
doi:

Substances chimiques

Antifungal Agents 0
Voriconazole JFU09I87TR

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106083

Informations de copyright

Copyright © 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.

Auteurs

Camille Bouchand (C)

Department of Pharmacy, Necker - Enfants Malades Hospital, AP-HP, Paris, France.

David Nguyen (D)

Department of Pharmacy, Necker - Enfants Malades Hospital, AP-HP, Paris, France.

Philippe-Henri Secretan (PH)

Department of Pharmacy, Necker - Enfants Malades Hospital, AP-HP, Paris, France.

Fabrice Vidal (F)

Department of Pharmacy, Necker - Enfants Malades Hospital, AP-HP, Paris, France.

Romain Guery (R)

Paris Descartes University, Infectious Diseases and Tropical Medicine Department, Necker-Enfants Malades Hospital, AP-HP, IHU Imagine, Paris, France.

Sylvain Auvity (S)

Department of Pharmacy, Necker - Enfants Malades Hospital, AP-HP, Paris, France; Inserm UMR-S 1144, Université Paris Descartes, Paris, France.

Jeremie F Cohen (JF)

Paris Descartes University, Infectious Diseases and Tropical Medicine Department, Necker-Enfants Malades Hospital, AP-HP, IHU Imagine, Paris, France.

Fanny Lanternier (F)

Paris Descartes University, Infectious Diseases and Tropical Medicine Department, Necker-Enfants Malades Hospital, AP-HP, IHU Imagine, Paris, France; Institut Pasteur, National Reference Center for Invasive Mycoses and Antifungals, Molecular Mycology Unit, CNRS UMR2000, Paris, France.

Olivier Lortholary (O)

Paris Descartes University, Infectious Diseases and Tropical Medicine Department, Necker-Enfants Malades Hospital, AP-HP, IHU Imagine, Paris, France; Institut Pasteur, National Reference Center for Invasive Mycoses and Antifungals, Molecular Mycology Unit, CNRS UMR2000, Paris, France.

Salvatore Cisternino (S)

Department of Pharmacy, Necker - Enfants Malades Hospital, AP-HP, Paris, France; Inserm UMR-S 1144, Université Paris Descartes, Paris, France.

Joël Schlatter (J)

Department of Pharmacy, Necker - Enfants Malades Hospital, AP-HP, Paris, France. Electronic address: joel.schlatter@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH